Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	QAW039 150mg	1,093
Overall Study	STARTED	QAW039 450 mg	1,085
Overall Study	STARTED	Placebo	360
Overall Study	Safety Set (SAF)	QAW039 150mg	1,092
Overall Study	Safety Set (SAF)	QAW039 450 mg	1,084
Overall Study	Safety Set (SAF)	Placebo	361
Overall Study	COMPLETED	QAW039 150mg	76
Overall Study	COMPLETED	QAW039 450 mg	71
Overall Study	COMPLETED	Placebo	32
Overall Study	NOT COMPLETED	QAW039 150mg	1,017
Overall Study	NOT COMPLETED	QAW039 450 mg	1,014
Overall Study	NOT COMPLETED	Placebo	328

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03052517/flow